Taha Al-Juhaishi to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Taha Al-Juhaishi has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.471
-
CAR-T in B-Cell Lymphomas: The Past, Present, and Future. Clin Lymphoma Myeloma Leuk. 2022 04; 22(4):e261-e268.
Score: 0.697
-
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2025 Aug; 31(8):494-504.
Score: 0.224
-
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. Am J Hematol. 2025 Jun; 100(6):987-997.
Score: 0.221
-
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leuk Lymphoma. 2022 03; 63(3):710-721.
Score: 0.174
-
Perspectives on chemotherapy for the management of double-hit lymphoma. Expert Opin Pharmacother. 2020 Apr; 21(6):653-661.
Score: 0.155